TrialJournal of gynecologic oncology2024

First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

Xiaohua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.